Review article: Externally derived control arms-An opportunity for clinical trials in inflammatory bowel disease?
Fiche publication
Date publication
août 2023
Journal
Alimentary pharmacology & therapeutics
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent
Tous les auteurs :
Honap S, Peyrin-Biroulet L
Lien Pubmed
Résumé
One of the greatest challenges in the current IBD clinical trial landscape is, perhaps, the recruitment and retention of eligible participants. Seamless testing of promising investigational compounds is paramount to address unmet needs, but this is hindered by a number of barriers, particularly patient concerns of placebo assignment.
Référence
Aliment Pharmacol Ther. 2023 08 21;: